“We are excited about what we represent and the work we do every day, ensuring access to health for patients everywhere in the U.S.”
Lynx Therapeutics through our innovative healthcare vendors and clinically proven powerful
therapies are empowering people’s lives. Many recent rare opportunities have
now sprung from treating various diseases. Through the power of modern medicine
and the messaging that our professional Pharmaceutical Sales Rep team can introduce
a powerful connection between a physician and their patient which can bring
life-changing hope. As an innovative pharmaceutical company, our success stems
from our unwavering focus on science and recommending therapies that can bring
relief to patients and their families.
As a leading
biopharmaceutical company, Lynx Therapeutics puts patients first in
everything we do. Patients inspire us in our mission to lead the science that
creates breakthrough diagnosis which will lead to selecting better therapies.
Our portfolio includes a range of world-class commercialized and developmental
healthcare products / services which can aid in diabetes, oncology,
respiratory, cardiology, immunology, and pharmacodynamics.
LYNX Therapeutics represents products from Pharmaceutical to Biotechnology and beyond.
Current biotechnology tools and techniques open new clinical research avenues for discovering how healthy bodies work and what goes wrong when problems arise. Knowing the molecular basis of health and disease leads to improved methods for treating and preventing diseases. In human health care, biotechnology products include quicker and more accurate diagnostic tests, therapies with fewer side effects and new and safer vaccines.
We can now detect many diseases and medical conditions more quickly and with greater accuracy because of new, biotechnology-based diagnostic tools. Biotechnology has lowered the costs of diagnostics in many cases. A blood test developed through biotechnology measures low-density lipoprotein ("bad" cholesterol) in one test, without fasting. We now use biotechnology-based tests to diagnose certain cancers, such as prostate and ovarian cancer, by taking a blood sample, eliminating the need for invasive and costly surgery.